Market Closed

GENB
Generate Biomedicines
$ 12.07
-3.98%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Generate Biomedicines News

Latest Generate Biomedicines Stock News & GENB Headlines

Generate Biomedicines Reports Third Quarter 2026 Financial Results and Provides Business Update
4 days ago | globenewswire.com
Generate Biomedicines to Participate in November Investor Conferences
25 days ago | globenewswire.com
Banque Pictet & Cie SA Buys New Position in Generate Biomedicines Inc $GENB
a month ago | defenseworld.net
Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
a month ago | globenewswire.com
Generate Biomedicines: The Dosing Interval Is The Moat, Not The Algorithm
a month ago | seekingalpha.com
Squarepoint Ops LLC Makes New $530,000 Investment in Generate Biomedicines Inc $GENB
2 months ago | defenseworld.net
Generate Biomedicines Inc. to Participate in September Investor Conferences
2 months ago | globenewswire.com
Generate Biomedicines stock jumps as post-IPO lock-up set to expire
3 months ago | proactiveinvestors.com
Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update
3 months ago | globenewswire.com
This Is Nvidia CEO Jensen Huang's Favorite Biotech Stock -- and You've Probably Never Heard of It
3 months ago | fool.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

GENB
Generate Biomedicines
$ 12.07
-3.98%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago